Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 13/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.79 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.79 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.79 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.79 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.79 |
| ▸ | GC | P02774 | 1/20 | 0.79 |
| ▸ | PGR | P06401 | 1/20 | 0.79 |
| ▸ | RXRA | P19793 | 1/20 | 0.79 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.79 |
| ▸ | CNR1 | P21554 | 1/20 | 0.79 |
| ▸ | HTR2C | P28335 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.79 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.79 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.79 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.79 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.79 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maxacalcitol SCHEMBL5617040 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL14490724 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL342279 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL5153677 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL25095406 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL17975926 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL24066887 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL4893368 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL20461177 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 | |
| Maxacalcitol SCHEMBL7203090 | 1.00 | VDR (1.00) | VDRMAPTADORA3SLC6A2AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2202 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616749-B2 | Methods for treatment of psoriasis with an anti-oxLDL antibody | ABCENTRA, LLC (US) | 2026-05-05 | — | — | US | claimed |
| EP-4710926-A1 | TOPICAL COMPOSITION | Api Co., Ltd. (JP) | 2026-03-18 | — | — | EP | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4590274-A1 | OIL-IN-WATER EMULSIONS FOR TOPICAL ADMINISTRATION AND USES THEREOF | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-30 | — | — | EP | claimed |
| WO-2025151443-A1 | ENDOXIFEN FOR TREATMENT OF RARE CANCERS | ATOSSA THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-12351551-B2 | Method for producing maxacalcitol, and intermediate therefor | YONSUNG FINE CHEMICAL CO., LTD. (KR) | 2025-07-08 | — | — | US | claimed |
| WO-2025129271-A1 | LIPID DELIVERY VEHICLE | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-06-26 | — | — | WO | claimed |
| EP-4570321-A2 | JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES | Incyte Corporation (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2025111447-A1 | TREATMENT OF CANCER WITH DRUG COMBINATIONS | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250161440-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF PSORIASIS | ABCENTRA, LLC | 2025-05-22 | — | — | US | claimed |
| EP-1051974-A1 | LOTIONS CONTAINING VITAMIN D 3 DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-11-15 | — | — | EP | claimed |
| WO-2000064450-A1 | PHARMACEUTICAL COMPOSITION | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) | 2000-11-02 | — | — | WO | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061604-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061541-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| EP-1040832-A1 | CREAMS CONTAINING VITAMIN D 3? DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-10-04 | — | — | EP | claimed |
| EP-0998925-A1 | MEDICINAL COMPOSITIONS FOR TOPICAL ADMINISTRATION CONTAINING VITAMIN D AND VITAMIN K | New Vision Co., Ltd. (JP) | 2000-05-10 | — | — | EP | claimed |
| EP-0992242-A1 | VITAMIN D-CONTAINING PREVENTIVES AND/OR REMEDIES FOR CONJUNCTIVAL/CORNEAL XEROSIS | New Vision Co., Ltd. (JP) | 2000-04-12 | — | — | EP | claimed |
| US-5876709-A | Ophthalmic composition containing active Vitamin D | NEW VISION CO., LTD. (JP) | 1999-03-02 | — | — | US | claimed |
| EP-0815862-A1 | OPHTHALMOLOGICAL COMPOSITION COMPRISING ACTIVATED VITAMIN D | Mukai, Katsuhiko (JP) | 1998-01-07 | — | — | EP | claimed |